TipRanks
Medicenna Therapeutics Corp (MDNAF)
OTHER OTC:MDNAF
US Market
MDNAF
Medicenna Therapeutics Corp
RESEARCH TOOLSreports

Medicenna Therapeutics Corp (MDNAF) Income Statement

251 Followers

Medicenna Therapeutics Corp Income Statement

Last quarter (Q1 2027), Medicenna Therapeutics Corp's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q1, Medicenna Therapeutics Corp's net income was C$-5.08M. See Medicenna Therapeutics Corp’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -77.00KC$ -55.00KC$ -5.00KC$ -5.00KC$ -38.00K
Operating Expenses
C$ 23.63MC$ 21.58MC$ 19.66MC$ 16.30MC$ 22.47M
Depreciation and Amortization
C$ 72.00KC$ 53.00KC$ 4.00KC$ 4.00KC$ 38.00K
EBITDA
C$ -23.64MC$ -12.98MC$ -18.67MC$ -16.30MC$ -22.54M
Operating Income
C$ -23.71MC$ -21.63MC$ -19.66MC$ -21.64MC$ -22.30M
Other Income/Expenses
C$ 4.01MC$ 8.60MC$ -5.80MC$ 7.00MC$ 1.65M
Pretax Income
C$ -19.70MC$ -13.03MC$ -25.47MC$ -10.05MC$ -22.58M
Net Income
C$ -18.41MC$ -11.80MC$ -25.47MC$ 1.55MC$ -22.65M
Per Share Metrics
Basic EPS
C$ -0.22C$ -0.15C$ -0.37C$ 0.02C$ -0.42
Diluted EPS
C$ -0.22C$ -0.15C$ -0.37C$ 0.02C$ -0.42
Weighted Average Shares Outstanding
 83.19M 76.67M 69.64M 64.74M 54.29M
Weighted Average Shares Outstanding (Diluted)
 83.19M 76.67M 69.64M 64.74M 54.29M
Currency in CAD

Medicenna Therapeutics Corp Earnings and Revenue History